EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-SA 4.0

A case series of vildagliptin-associated bullous pemphigoid - Rare side effect

Mohit Kumar Shahi, J V Ashwin, Astha Singh, Suvrat Gupta, K Surya

Indian Journal of Pharmacology · 2025

DOI: 10.4103/ijp.ijp_522_24 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Indian Journal of Pharmacology, 2025. Verfasst von Mohit Kumar Shahi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of GMH, King George Medical University, Lucknow, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Adamantane, Dipeptidyl-Peptidase IV Inhibitors, Nitriles, Pemphigoid, Bullous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vildagliptin, among the most commonly used, OHA, belongs to group dipeptidyl peptidase-4 inhibitors for managing type 2 diabetes mellitus, has recently been associated with bullous pemphigoid, characterized by fluid-filled blisters and erosions on the skin and mucous membranes. We report the series of three cases of bullous pemphigoid in patients of diabetes, who developed bullous pemphigoid after vildagliptin use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdamantaneDipeptidyl-Peptidase IV InhibitorsNitrilesPemphigoid, BullousPyrrolidinesHumansDiabetes Mellitus, Type 2Vildagliptin

Stichwörter der Autor:innen

Bullous pemphigoiddiabetesdipeptidyl peptidase-4vildagliptin

Substanzen

AdamantaneDipeptidyl-Peptidase IV InhibitorsNitrilesPyrrolidinesVildagliptin

Autor:innen und Institutionen

  • Department of GMH, King George Medical University, Lucknow, Uttar Pradesh, India.
  • Department of Psychiatry, Hind Institute of Medical Sciences, Barabanki, Uttar Pradesh, India.
  • Department of PMR, Hind Institute of Medical Sciences, Barabanki, Uttar Pradesh, India.
  • Department of Pharmacology, King George Medical University, Lucknow, Uttar Pradesh, India.

Zitieren

APA

Shahi, M. K., Ashwin, J. V., Singh, A., Gupta, S., & Surya, K. (2025). A case series of vildagliptin-associated bullous pemphigoid - Rare side effect. Indian Journal of Pharmacology. https://doi.org/10.4103/ijp.ijp_522_24

Vancouver

Shahi MK, Ashwin JV, Singh A, Gupta S, Surya K. A case series of vildagliptin-associated bullous pemphigoid - Rare side effect. Indian Journal of Pharmacology. 2025. doi:10.4103/ijp.ijp_522_24

BibTeX
@article{Shahi2025,
  author = {Shahi, Mohit Kumar and Ashwin, J V and Singh, Astha and Gupta, Suvrat and Surya, K},
  title = {A case series of vildagliptin-associated bullous pemphigoid - Rare side effect},
  journal = {Indian Journal of Pharmacology},
  year = {2025},
  doi = {10.4103/ijp.ijp_522_24}
}
Kostenlos starten →